Skip to main content

. 1997 Oct;90(10):561–562. doi: 10.1177/014107689709001009

Blood gas deterioration after cholecystokinin administration in an infant.

C A Hajivassiliou ¹, G A MacKinlay ¹

PMCID: PMC1296599 PMID: 9488015

561

Images in this article

Figure 2
on p.561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bauer F. E., von Kleist D., Janisch H. D., Hampel K. E. Changes in the blood gas concentration caused by secretin and cholecystokinin. Indication of a vasomotor effect? J Clin Gastroenterol. 1986 Jun;8(3 Pt 1):263–266. doi: 10.1097/00004836-198606000-00012. [DOI] [PubMed] [Google Scholar]
Bloom S. R., Polak J. M. Regulatory peptides and the lung. Pediatr Pulmonol. 1985 May-Jun;1(3 Suppl):S30–S36. [PubMed] [Google Scholar]
Polak J. M., Bloom S. R. Regulatory peptides of the gastrointestinal and respiratory tracts. Arch Int Pharmacodyn Ther. 1986 Apr;280(2 Suppl):16–49. [PubMed] [Google Scholar]
Rintala R. J., Lindahl H., Pohjavuori M. Total parenteral nutrition-associated cholestasis in surgical neonates may be reversed by intravenous cholecystokinin: a preliminary report. J Pediatr Surg. 1995 Jun;30(6):827–830. doi: 10.1016/0022-3468(95)90758-0. [DOI] [PubMed] [Google Scholar]
Stretton C. D., Barnes P. J. Cholecystokinin-octapeptide constricts guinea-pig and human airways. Br J Pharmacol. 1989 Jul;97(3):675–682. doi: 10.1111/j.1476-5381.1989.tb12003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES